Xceleron Adds to Team

Xceleron, a UK-based drug development company, has named David Roblin to its board, and added Stuart Best as senior director operations. Roblin joins from Pfizer Global R&D where he was most recently senior vice president R&D, research head and site director. Best joins Xceleron from Merck, Scotland where he was head of bioanalysis. Xceleron is backed by Close Ventures and Foursome Inv*stments.

PeopleNorth AmericaUSBriefs